ASCEND BY NTHRYS
Research Abroad Products

General Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 97–108 of 200 project topics
Disease Activity Index Standardization Enterprise Platform
Integrated software that harmonizes disparate autoimmune disease activity scoring systems across clinical sites and hospital networks. Enables data aggregation for real-world evidence generation and creates valuable datasets for licensing to biopharmaceutical companies.
Autoimmune Disease Immunology Platform Dev Click to view more details →
Immune Tolerance Restoration Protocol Development Service
Consulting and analytical service that designs personalized immunotherapy protocols for treating refractory autoimmune conditions. Generates B2B service revenue through partnerships with leading academic medical centers and specialty pharmaceutical firms.
Autoimmune Disease Immunology Platform Dev Click to view more details →
Autoimmune Disease Registry and Market Intelligence Platform
Cloud-based registry aggregating de-identified patient data, treatment outcomes, and immunological profiles across autoimmune conditions. Monetizes through real-world evidence licensing, patient recruitment services, and predictive market analytics for pharmaceutical companies.
Autoimmune Disease Immunology Platform Dev Click to view more details →
Checkpoint Inhibitor Toxicity Prediction AI System
Deep learning platform that predicts autoimmune adverse events from checkpoint inhibitor cancer therapies using immunological biomarker integration. Licenses to oncology hospitals and pharmaceutical companies as a risk management tool protecting patient safety and reducing litigation exposure.
Autoimmune Disease Immunology Platform Dev Click to view more details →
Real-Time Tumor Microenvironment Profiling SaaS Platform
A cloud-based analytics platform that processes multi-omics data to generate dynamic immune cell composition maps within patient tumors. Enables oncologists to make personalized immunotherapy decisions, reducing treatment failures and increasing patient response rates by 30-40%.
Cancer Immunology Analytics Platform Dev Click to view more details →
AI-Powered Checkpoint Inhibitor Response Prediction Engine
Machine learning software that analyzes PD-L1 expression, TCR diversity, and immune infiltration patterns to forecast patient outcomes with checkpoint inhibitor therapies. Pharma companies reduce clinical trial failure rates and accelerate drug development timelines by 18-24 months.
Cancer Immunology Analytics Platform Dev Click to view more details →
Cancer Immune Cell Enumeration and Phenotyping Tool Suite
Automated image analysis software that quantifies and characterizes tumor-infiltrating lymphocytes from pathology slides and imaging data at scale. Laboratories increase throughput 5-fold while reducing manual analysis costs by 60% and enabling high-confidence biomarker discovery.
Cancer Immunology Analytics Platform Dev Click to view more details →
Personalized CAR-T Cell Design Optimization Platform
An in silico design tool that predicts optimal CAR-T configurations based on patient-specific tumor antigen expression and immune landscape data. Cell therapy manufacturers improve manufacturing success rates, reduce development cycles, and increase per-patient efficacy by 25-35%.
Cancer Immunology Analytics Platform Dev Click to view more details →
Tumor Neoantigen Load Analytics and Immunogenicity Scoring
A bioinformatics SaaS platform that identifies personalized neoantigens, predicts HLA-peptide binding, and scores immunogenicity for cancer vaccine development. Biotech companies accelerate personalized medicine programs and reduce vaccine manufacturing turnaround from 6 months to 8-12 weeks.
Cancer Immunology Analytics Platform Dev Click to view more details →
Multi-Parameter Immune Dysfunction Assessment Dashboard
A clinical analytics dashboard aggregating T cell exhaustion markers, regulatory T cell frequency, myeloid-derived suppressor cells, and immunosuppressive cytokine profiles. Oncology centers identify patients most likely to benefit from combination immunotherapies, improving response rates and treatment ROI.
Cancer Immunology Analytics Platform Dev Click to view more details →
Immunotherapy Resistance Mechanism Detection and Reporting System
Software that analyzes sequential tumor biopsies to identify mechanistic drivers of immunotherapy resistance including epithelial-mesenchymal transition, microbiome composition, and metabolic reprogramming. Clinical networks generate actionable insights for treatment switches, reducing wasted therapy cycles and improving long-term survival outcomes.
Cancer Immunology Analytics Platform Dev Click to view more details →
Spatial Immune Architecture Mapping and Visualization Platform
A high-dimensional spatial analysis tool that maps immune cell localization, tertiary lymphoid structures, and stromal interactions directly on tumor tissue sections. Researchers and clinicians uncover spatial biomarkers for immunotherapy response, enabling stratified clinical trial design and precision medicine applications.
Cancer Immunology Analytics Platform Dev Click to view more details →